论文部分内容阅读
本文用免疫粘附血凝法(IAHA)测定了慢性迁延性肝炎(CPH)75例、慢性活动性肝炎(CAH)40例、肝硬化(LC)83例、原发性肝癌(PHC)20例、正常人(NH)42例的红细胞补体受体(CR_1)活性,并初步探讨肝病患者CR_1活性与血清免疫复合物(IC)总补体活性(CH_(50))及sGPT等的相互关系。
In this paper, 75 cases of chronic persistent hepatitis (CPH), 40 cases of chronic active hepatitis (CAH), 83 cases of liver cirrhosis (LC), 20 cases of primary liver cancer (PHC) were measured by immunoadhesive hemagglutination assay (IAHA) , Normal human (NH) 42 patients with erythrocyte complement receptor (CR_1) activity, and preliminary study of liver disease CR_1 activity and serum immune complex (IC) total complement activity (CH_50) and sGPT and so on.